JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.

EGFR

EGFR (epidermal growth factor receptor) is the cell-surface receptor of its specific ligands, including epidermal growth factor and TGFα (transforming growth factor α) and is a receptor tyrosine kinase.

A4092 CUDC-101
1 Citation

Target: Histone Deacetylases (HDACs)|EGFR|ErbB

Summary: Multitargeted HDAC inhibitor

≥21.7 mg/mL
A4139 AG-490
3 Citation

Target: EGFR|JAK

Summary: JAK2/EGFR inhibitor

insoluble in H2O; ≥14.7 mg/mL
A3240 BIBX 1382

Summary: EGFR inhibitor,potent and selective

Soluble in DMSO
A3256 BMS-690514

Summary: HER/EGFR inhibitor

Soluble in DMSO
A3320 CO-1686 (AVL-301)
1 Citation

Target: EGFR

Summary: EGFR inhibitor

≥27.8 mg/mL
A3397 Erlotinib
4 Citation

Summary: EGFR tyrosine kinase inhibitor

insoluble in H2O; ≥19.65 mg/mL
A3433 Gefitinib hydrochloride

Target: EGFR

Summary: Potent EGFR inhibitor

insoluble in EtOH; ≥4.28 mg/mL
A3482 Icotinib Hydrochloride

Summary: EGFR inhibitor,potent and specific

Soluble in DMSO
A3513 Ixabepilone

Summary: Epothilone B analog;microtubule-stabilizing agent

≥22.25 mg/mL